Recent advances in genomic research for breast cancer include the application of CRISPR-Cas9 gene editing technology. This innovative approach allows scientists to make precise alterations to the DNA of breast cancer cells, potentially correcting genetic mutations that lead to the disease. By targeting specific genes associated with breast cancer, such as BRCA1 and BRCA2, researchers hope to develop more effective and personalized treatments.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.